Exane Derivatives’s PotlatchDeltic PCH Stock Holding History

Exane Derivatives’s Portfolio PCH Stock Details PCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$131K	Buy	+2,960	New	+$153K	0.08%	238
2022 Q1	–	Sell	-670	Closed	-$40.3K	–	1074
2021 Q4	$40.3K	Sell	670 -131	-16%	-$7.34K	0.01%	519
2021 Q3	$41.3K	Sell	801 -2,049	-72%	-$107K	0.01%	638
2021 Q2	$152K	Buy	2,850 +2,839	+25,809%	+$164K	0.03%	476
2021 Q1	$582	Sell	11 -195	-95%	-$10.1K	﹤0.01%	782
2020 Q4	$10.3K	Buy	+206	New	+$9.48K	﹤0.01%	525

Other funds holding PCH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Exane Derivatives's PCH Position: Q2 2022 in Review

Exane Derivatives opened a new position in PotlatchDeltic (PCH) in Q2 2022: 2,960 shares worth $131K. The stake represents 0.08% of the portfolio and ranks #238 among its holdings. This is a return to the name: Exane Derivatives previously reported a position in PCH as recently as Q4 2021.

Exane Derivatives first reported a position in PCH in Q4 2020 and has held it in 6 quarters since. The position peaked at $152K in Q2 2021. 321 funds tracked by Wall St. Rank hold PCH as of Q2 2022.

Exane Derivatives held 2,960 shares of PotlatchDeltic worth $131K as of Q2 2022.
PotlatchDeltic was a new Exane Derivatives position in Q2 2022.
PotlatchDeltic made up 0.08% of Exane Derivatives's portfolio in Q2 2022, its #238 holding.
Exane Derivatives first reported a position in PotlatchDeltic in Q4 2020 and has held it in 6 quarters since.
Exane Derivatives's PotlatchDeltic position peaked at $152K in Q2 2021.
321 funds tracked by Wall St. Rank held PotlatchDeltic as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.